Clinical Trial Update: Biomarker-Driven Radiation Therapy Dose Reduction After Transoral Robotic Surgery for the Treatment of HPV-Positive Oropharyngeal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial explores biomarker-guided reduction of radiation therapy dose following transoral robotic surgery for HPV-positive oropharyngeal cancer; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Emory University | Conditions: Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Oropharyngeal HPV-Positive Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING